Supported by different recognition modes of Trop-2 by 2EF and 2G10, synergy between 2EF and 2G10 against tumor xenotransplants was demonstrated, opening novel avenues for Trop-2-targeted therapy (Guerra et al., 2023b). This evidence concerns the gene TACSTD2 and neoplasm.